What development phase is Actamer in?

Actamer is FDA-approved (marketed).

What is the generic name of Actamer?

BITHIONOL is the generic (nonproprietary) name of Actamer.

Last reviewed 2026-04-20 · How we verify

Actamer (BITHIONOL)

FDA-approved withdrawn Small molecule Quality 10/100

At a glance

Generic name	BITHIONOL
Drug class	bithionol
Target	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D, Adenosine receptor A3, Mitogen-activated protein kinase 1
Modality	Small molecule
Therapeutic area	Rare Disease
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Actamer CI brief — competitive landscape report
Actamer updates RSS · CI watch RSS